483 AveXis Aug 2019

483 AveXis Aug 2019

Scott Ballard FDA, Mihaly Ligmond FDA$119.00 - Available Now

FDA investigators audited the AveXis - San Diego, CA, United States facility and issued inspectional observations (via FDA 483) on 02 Aug 2019.

Product details

  • Category: Biologics
  • Inspection end: 02 Aug 2019
  • Location: San Diego, United States
  • FEI: 3014617030
Add To Cart